Oral Hydromorphone Conversion from 1.5 mg IV Dilaudid
1.5 mg of intravenous (IV) Dilaudid (hydromorphone) converts to 7.5 mg of oral hydromorphone using the standard conversion factor of 5 (range 2.5-5) 1.
Conversion Calculation
The 2025 NCCN Adult Cancer Pain Guidelines provide explicit equianalgesic dosing in their opioid conversion table 1:
- Parenteral (IV) hydromorphone: 1.5 mg
- Oral hydromorphone: 7.5 mg
- IV to PO conversion factor: 2.5-5
Using the direct conversion from the guideline table:
- 1.5 mg IV hydromorphone = 7.5 mg oral hydromorphone
Important Clinical Considerations
When converting from IV to oral, reduce the calculated equianalgesic dose by 25-50% to account for incomplete cross-tolerance if the patient was well-controlled on the IV dose 2. However, if pain was inadequately controlled, you may use 100% of the equianalgesic dose or even increase by 25% 2.
Renal Function Caution
Hydromorphone should be used with extreme caution in patients with fluctuating renal function due to potential accumulation of renally cleared metabolites that can cause neurologic toxicity, including confusion, drowsiness, and hallucinations 1. In patients with moderate to severe renal dysfunction (eGFR <30 mL/min), fentanyl or buprenorphine are preferred alternatives 3, 4.
Dosing Schedule
- Duration of action: 2-3 hours for immediate-release oral hydromorphone 1
- Schedule around-the-clock dosing with breakthrough doses available
- Breakthrough dose should be approximately 10% of total daily dose 5, 4
Alternative Conversion Pathways
If converting to other oral opioids instead of oral hydromorphone:
To oral morphine:
- 1.5 mg IV hydromorphone → 10 mg IV morphine (using 1:6.67 ratio)
- 10 mg IV morphine → 30 mg oral morphine (using 1:3 ratio)
- Therefore: 1.5 mg IV hydromorphone ≈ 30 mg oral morphine
To oral oxycodone:
- Using morphine equivalents: 30 mg oral morphine ≈ 15-20 mg oral oxycodone 1
Morphine Milligram Equivalents (MME)
For reference, 1.5 mg IV hydromorphone equals:
This conversion is critical for monitoring total opioid burden and adhering to prescribing guidelines that recommend caution at ≥50 MME/day 7.